Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Michalovce – page 17

240 clinical trials in Michalovce, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Michalovce at a glance
240
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

240 trials in Michalovce

Open in trial search

Study on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Crizotinib
  • Sponsor:F. Hoffmann-La Roche AG

Hypertension

Not recruiting

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Janssen Cilag International

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Rheumatoid arthritis

Not recruiting

Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Rosnilimab
  • Sponsor:Anaptysbio Inc.

Schizophrenia

Not recruiting

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Valbenazine Ditosylate
  • Sponsor:Neurocrine Biosciences Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Registered drug
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:MRNA-4157
  • Sponsor:Merck Sharp & Dohme LLC

Hypertension

Not recruiting

Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Michalovce

What the registry says about research in the country

01 Breast Cancer Research

Comprehensive studies focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer, evaluating novel therapeutic combinations and treatment approaches for advanced and metastatic cases.

  • Advanced treatment combinations
  • Metastatic disease management
  • Hormone therapy resistance

Multiple trials investigating innovative therapeutic options for patients who have progressed after initial treatments.

02 Respiratory Medicine

Research examining new treatments for moderate to severe asthma, including studies of innovative inhaler formulations and delivery systems to improve patient outcomes.

  • Asthma management
  • Respiratory drug delivery
  • Bronchial response studies

Evaluation of advanced inhaler technologies and their safety profiles in controlled asthma patients.

03 Infectious Diseases

Investigations into treatment options for community-acquired pneumonia (CAP) and COVID-19, testing novel therapeutic approaches in combination with standard care protocols.

  • Pneumonia treatment
  • COVID-19 interventions
  • Immunological responses

Studies focusing on adjunctive treatments to improve outcomes in hospitalized patients.

04 Oncology & Immunotherapy

Advanced research in non-small cell lung cancer (NSCLC) treatment, exploring innovative immunotherapy combinations and targeted therapies for various cancer stages.

  • Post-surgical treatment
  • Immunotherapy combinations
  • Cancer progression prevention

Evaluation of novel therapeutic approaches in cancer treatment following standard interventions.

05 Hepatology

Innovative research examining treatments for non-alcoholic steatohepatitis (NASH), focusing on improving liver histology and reducing liver-related clinical events.

  • Liver disease management
  • Fibrosis treatment
  • Disease progression prevention

Clinical evaluation of therapeutic interventions for various stages of liver fibrosis.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.